SCHEMBL30906752

SCHEMBL30906752

COC(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](N)C1CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PEPD P12955 7/20 0.66
XPNPEP1 Q9NQW7 3/20 0.66
POLB P06746 1/20 0.49
FKBP1A P62942 2/20 0.41
ACE P12821 4/20 0.40
REN P00797 2/20 0.40
KDM4E B2RXH2 1/20 0.40
F2 P00734 1/20 0.40
LMNA P02545 1/20 0.40
LTA4H P09960 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
PTGS1 P23219 1/20 0.40
HTR2A P28223 1/20 0.40
PTGS2 P35354 1/20 0.40
HRH1 P35367 1/20 0.40
THPO P40225 1/20 0.40
PMP22 Q01453 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ACE2 Q9BYF1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30906700 0.83 PEPD (0.62) PEPDXPNPEP1POLBFKBP1AACE
SCHEMBL28594897 0.81 PEPD (0.59) PEPDXPNPEP1POLBFKBP1AACE
SCHEMBL9532959 0.81 PEPD (0.59) PEPDXPNPEP1POLBFKBP1AACE
SCHEMBL6374536 0.81 PEPD (0.59) PEPDXPNPEP1POLBFKBP1AACE
SCHEMBL30906733 0.80 PEPD (1.00) PEPDXPNPEP1POLBFKBP1A
Hydrochloric Acid SCHEMBL29398468 0.80 PEPD (0.57) PEPDXPNPEP1POLBFKBP1AACE
SCHEMBL30906715 0.79 PEPD (0.71) PEPDXPNPEP1POLBFKBP1AACE
SCHEMBL22811129 0.79 DPP4 (0.56) PEPDXPNPEP1POLBFKBP1A
SCHEMBL22209456 0.79 DPP4 (0.56) PEPDXPNPEP1POLBFKBP1A
Hydrochloric Acid SCHEMBL11569047 0.79 PEPD (0.57) PEPDXPNPEP1POLBFKBP1AACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368624-A1 M24B AMINOPEPTIDASE INHIBITORS FOR CARD8 INFLAMMASOME ACTIVATION MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2025-12-04 US disclosed
WO-2024077087-A2 M24B AMINOPEPTIDASE INHIBITORS FOR CARDS INFLAMMASOME ACTIVATION MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2024-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250368624-A1 M24B AMINOPEPTIDASE INHIBITORS FOR CARD8 INFLAMMASOME ACTIVATION PYCARD, NLRP3, CARD19 PEPD 61/4885XPNPEP1 41/4885POLB 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.